LON:CREO Creo Medical Group (CREO) Share Price, News & Analysis → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free CREO Stock Alerts GBX 35.48 +0.23 (+0.65%) (As of 05/3/2024 07:36 PM ET) Add Compare Share Share Today's Range 34.50▼ 35.5050-Day Range 29.55▼ 39.5052-Week Range 22.72▼ 50Volume347,808 shsAverage Volume714,286 shsMarket Capitalization£128.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get Creo Medical Group alerts: Email Address Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… About Creo Medical Group Stock (LON:CREO)Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, the United Kingdom.Read More CREO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CREO Stock News HeadlinesMay 6, 2024 | msn.comThe Welsh firms winning the King's Awards for Enterprise 2024May 4, 2024 | msn.comThe Welsh firms winning King's Awards for Enterprise 2024May 6, 2024 | InvestorPlace (Ad)Elon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” May 1, 2024 | msn.comPTC (PTC) Q2 2024 Earnings Call TranscriptApril 30, 2024 | msn.comThe incredible invention made in Wales that could transform cancer careApril 24, 2024 | lse.co.ukTRADING UPDATES: ActiveOps sales up; Sancus turnover jumpsApril 24, 2024 | finance.yahoo.comCreo Medical says NHS case study reveals significant efficiencies from Speedboat technologyApril 24, 2024 | uk.investing.comCreo Medical technology leads to significant efficiencies, NHS case study findsMay 6, 2024 | InvestorPlace (Ad)Elon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” April 19, 2024 | bizjournals.comNew renderings released of OhioHealth Grant Medical Center's downtown expansionApril 9, 2024 | uk.finance.yahoo.comBlackRock Greater Europe Investment Trust Plc - Total Voting RightsMarch 11, 2024 | lse.co.ukGlobalworth Real Estate sells logistics portfolio for EUR70 millionMarch 11, 2024 | theglobeandmail.comVancouver readies for its position as a global pharma capital as B.C.'s biotech boom takes offFebruary 20, 2024 | bizjournals.comHouston developer picks Medical Center for next 'flexible office' outpostFebruary 17, 2024 | morningstar.comCreo Medical Group PLCFebruary 12, 2024 | finance.yahoo.comCreo Medical Group expands reach of Speedboat UltraSlim; announces tie-up with Abu Dhabi universityFebruary 12, 2024 | finance.yahoo.comCreo Medical ends "pivotal" 2023 year with clear path to cashflow breakevenFebruary 3, 2024 | msn.com10 physicians at Conemaugh Physician Group furloughedFebruary 1, 2024 | tmcnet.comCreo Engine Listed on Binance-Powered Tokocrypto, Indonesia's Leading Digital Assets PlatformJanuary 31, 2024 | lse.co.ukTRADING UPDATES: Creo unveils product in APAC; Unilever hires directorJanuary 29, 2024 | ca.finance.yahoo.comCreo Medical Group PLC (CREO.L)January 28, 2024 | finance.yahoo.comWith 67% ownership of the shares, Creo Medical Group PLC (LON:CREO) is heavily dominated by institutional ownersJanuary 10, 2024 | proactiveinvestors.comProactive news headlines: Creo Medical, Cornerstone, Seeing Machines, Belvoir, and moreNovember 27, 2023 | proactiveinvestors.comExpert view on Creo's techNovember 27, 2023 | finance.yahoo.comCreo Medical Group reveals good growth prospects at Capital Markets Day - Proactive Research AnalystNovember 15, 2023 | morningstar.comCreo Medical Group PLC CREONovember 13, 2023 | finance.yahoo.comInvestors in Creo Medical Group (LON:CREO) have unfortunately lost 82% over the last five yearsSee More Headlines Receive CREO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/23/2020Today5/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:CREO CUSIPN/A CIKN/A Webcreomedical.com Phone+44-1291-606005FaxN/AEmployees279Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-25,040,000.00 Net Margins-85.54% Pretax MarginN/A Return on Equity-38.49% Return on Assets-19.98% Debt Debt-to-Equity Ratio13.33 Current Ratio4.13 Quick Ratio2.19 Sales & Book Value Annual Sales£29.27 million Price / Sales4.32 Cash FlowGBX 14.40 per share Price / Cash Flow2.43 Book ValueGBX 26 per share Price / Book1.35Miscellaneous Outstanding Shares361,480,000Free FloatN/AMarket Cap£126.52 million OptionableNot Optionable Beta0.86 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Craig Jonathan Gulliford (Age 54)CEO & Executive Director Comp: $472.66kProf. Christopher Paul Hancock (Age 57)Founder, CTO & Executive Director Comp: $360.17kMr. Richard John Rees ACA (Age 48)CFO, Company Secretary & Executive Director Comp: $359.8kMr. David Gerard Woods (Age 59)Chief Commercial Officer & Executive Director Comp: $446.38kMr. Phil HalesSales & Marketing DirectorKey CompetitorsEKF DiagnosticsLON:EKFNovacytLON:NCYTMaxCyteLON:MXCTNIOX GroupLON:NIOXAllergy TherapeuticsLON:AGYView All Competitors CREO Stock Analysis - Frequently Asked Questions How have CREO shares performed in 2024? Creo Medical Group's stock was trading at GBX 46 at the beginning of the year. Since then, CREO shares have decreased by 22.9% and is now trading at GBX 35.48. View the best growth stocks for 2024 here. How were Creo Medical Group's earnings last quarter? Creo Medical Group PLC (LON:CREO) announced its quarterly earnings data on Wednesday, September, 23rd. The company reported ($6.00) earnings per share for the quarter. Creo Medical Group had a negative net margin of 85.54% and a negative trailing twelve-month return on equity of 38.49%. What other stocks do shareholders of Creo Medical Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Creo Medical Group investors own include MySQUAR (MYSQ) and IQE (IQE). How do I buy shares of Creo Medical Group? Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CREO) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance Gold41 banks launch ‘crypto dollar’Stansberry ResearchDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.